| 11.885 0.055 (0.46%) | 09-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 14.37  |
1-year : | 16.79 |
| Resists | First : | 12.31 |
Second : | 14.37 |
| Pivot price | 11.74 |
|||
| Supports | First : | 11.59 |
Second : | 11.14 |
| MAs | MA(5) : | 11.76 |
MA(20) : | 11.72 |
| MA(100) : | 9.93 |
MA(250) : | 8.7 |
|
| MACD | MACD : | 0.2  |
Signal : | 0.3 |
| %K %D | K(14,3) : | 43.7 |
D(3) : | 40.8 |
| RSI | RSI(14): 59.1 |
|||
| 52-week | High : | 12.85 | Low : | 4.9 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NEOG ] has closed below upper band by 28.1%. Bollinger Bands are 55.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 12.33 - 12.37 | 12.37 - 12.41 |
| Low: | 11.67 - 11.73 | 11.73 - 11.77 |
| Close: | 11.8 - 11.89 | 11.89 - 11.96 |
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
Tue, 08 Sep 2026
Neogen (NEOG) Rebounds As Margin Recovery Raises The Question Of Value - simplywall.st
Tue, 08 Sep 2026
A business transformation plan will take center stage at Neogen's Oct. 7 event - Stock Titan
Sun, 06 Sep 2026
Jupiter Topco LLC Buys New Stake in Neogen Corporation $NEOG - MarketBeat
Sun, 06 Sep 2026
The Manufacturers Life Insurance Company Takes $956,000 Position in Neogen Corporation $NEOG - MarketBeat
Sat, 05 Sep 2026
Neogen Stock Price Forecast. Should You Buy NEOG? - StockInvest.us
Sat, 05 Sep 2026
Legal & General Group Plc Makes New Investment in Neogen Corporation $NEOG - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 218 (M) |
| Shares Float | 217 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 111.4 (%) |
| Shares Short | 9,930 (K) |
| Shares Short P.Month | 10,790 (K) |
| EPS | -0.04 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.6 |
| Profit Margin | -1 % |
| Operating Margin | 1.3 % |
| Return on Assets (ttm) | -0.5 % |
| Return on Equity (ttm) | -0.4 % |
| Qtrly Rev. Growth | -0.2 % |
| Gross Profit (p.s.) | 1.87 |
| Sales Per Share | 3.99 |
| EBITDA (p.s.) | 0.43 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 83 (M) |
| Levered Free Cash Flow | 70 (M) |
| PE Ratio | -297.13 |
| PEG Ratio | 0.6 |
| Price to Book value | 1.23 |
| Price to Sales | 2.97 |
| Price to Cash Flow | 31.15 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|